Literature DB >> 18091602

The new insulins.

Stephen Crotty1, Sally L Reynolds.   

Abstract

Diabetes is a growing problem for a large proportion of children. Insulin is the primary medication used for most cases of pediatric diabetes, though achieving adequate glycemic control with current insulin products can be extremely challenging. New insulin forms, including novel analogues and radically changed delivery systems are providing new approaches to controlling diabetes. Health care providers caring for patients with diabetes must be informed of the new insulins becoming available to patients. This CME article will provide an introduction to some of the new insulins and delivery systems.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18091602     DOI: 10.1097/pec.0b013e31816121ba

Source DB:  PubMed          Journal:  Pediatr Emerg Care        ISSN: 0749-5161            Impact factor:   1.454


  2 in total

1.  Long-acting insulin analogues elicit atypical signalling events mediated by the insulin receptor and insulin-like growth factor-I receptor.

Authors:  E Yehezkel; D Weinstein; M Simon; R Sarfstein; Z Laron; H Werner
Journal:  Diabetologia       Date:  2010-09-12       Impact factor: 10.122

2.  Genome-Wide Analyses Identify Filamin-A As a Novel Downstream Target for Insulin and IGF1 Action.

Authors:  Daniel Aizen; Metsada Pasmanik-Chor; Rive Sarfstein; Zvi Laron; Ilan Bruchim; Haim Werner
Journal:  Front Endocrinol (Lausanne)       Date:  2018-03-20       Impact factor: 5.555

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.